Research Article


DOI :10.26650/IUITFD.2020.0089   IUP :10.26650/IUITFD.2020.0089    Full Text (PDF)

INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER

Didem AyhanNeşe MercanReyhan DoğanÇiğdem Yüksel

Objective: This study aimed to examine the levels of distress and alexithymia and the relationship between these two variables in individuals diagnosed with hematological cancer. Material and Method: This descriptive study was conducted between February and June 2018 with 135 individuals between the ages of 18 and 65 who were diagnosed with hematological cancer, who were undergoing inpatient and outpatient treatment in the hematology clinic of a training and research hospital, and who agreed to participate in the study. The data of the study were collected by introductory information form in line with the James Supportıve Care Screenıng and Toronto Alexithymia Scale. Results: In this study, the mean score of James Supportıve Care Screenıng was 50.2±21.2 and the mean score of the Toronto Alexithymia Scale was found to be 52.3±10.2. As a result of the correlation analysis, a moderate, positively significant correlation was found between the distress and alexithymia levels of individuals diagnosed with hematological cancer (r=0.412; p<0.001). Conclusion: This study concluded that alexithymic features could be observed in individuals diagnosed with hematological cancer as their distress levels increased. According to these results, it is suggested that healthcare professionals should support patients and intervene with regard to coping with stress, recognizing and expressing their feelings at the health service delivery.

DOI :10.26650/IUITFD.2020.0089   IUP :10.26650/IUITFD.2020.0089    Full Text (PDF)

HEMATOLOJİK KANSER TANISI ALAN BİREYLERDE DİSTRES VE ALEKSİTİMİNİN İNCELENMESİ

Didem AyhanNeşe MercanReyhan DoğanÇiğdem Yüksel

Amaç: Bu çalışmada hematolojik kanser tanısı alan bireylerde distres ve aleksitimi düzeylerinin belirlenmesi ve bu iki değişken arasındaki ilişkinin incelenmesi amaçlanmıştır. Gereç ve Yöntem: Tanımlayıcı nitelikteki bu araştırma, bir eğitim araştırma hastanesinin hematoloji kliniğinde yatarak ve ayaktan tedavi görmekte olan hematolojik kanser tanısına sahip, 18-65 yaşları arasında, araştırmaya katılmayı kabul eden 135 birey ile Şubat-Haziran 2018 tarihleri arasında yürütülmüştür. Araştırmanın verileri, tanıtıcı bilgi formu, James Destekleyici Bakım Gereksinimlerini Belirleme Ölçeği ve Toronto Aleksitimi Ölçeği ile toplanmıştır. Bulgular: Bu çalışmada James Destekleyici Bakım Gereksinimlerini Belirleme Ölçeği ortalama puanı 50,2±21,2; Toronto Aleksitimi Ölçeği ortalama puanı 52,3±10,2 olarak bulunmuştur. Yapılan korelasyon analizi sonucunda, hematolojik kanser tanısı alan bireylerin distres ve aleksitimi seviyeleri arasında orta şiddette, pozitif yönlü anlamlı bir ilişki bulunmuştur (r=0,412; p<0,001). Sonuç: Bu çalışma ile hematolojik kanser tanısı olan bireylerde distres seviyeleri arttıkça aleksitimik özellikler gözlenebildiği sonucuna varılmıştır. Bu sonuçlar doğrultusunda sağlık hizmetleri sunumunda bireylerin stresle başetme, duygularını tanıma ve ifade etme gibi konularda sağlık profesyonelleri tarafından desteklenmesi ve psikososyal müdahalelerin yapılması önerilmektedir.


PDF View

References

  • 1. T.C. Sağlık Bakanlığı. Türkiye onkoloji hizmetleri yeniden yapılanma programı 2010-2023. 2010; google scholar
  • 2. Çalışkan E, Gürhan N, Tekgündüz AİE. Distress, anxiety and depression in patients Who have received hematologic cancer diagnosis. Acta Oncol Turc 2017;50(3):207-17. [CrossRef] google scholar
  • 3. Albrecht TA, Rosenzweig M. Distress in patients with acute Leukemia: A concept analysis. Cancer Nurs 2014;37(3):218-26. [CrossRef] google scholar
  • 4. Liao MN, Chen SC, Chen SC, Lin YC, Chen MF, Wang CH, et al. Change and predictors of symptom distress in breast cancer patients following the first 4 months after diagnosis. J Formos Med Assoc [Internet]. 2015;114(3):246-53. [CrossRef] google scholar
  • 5. Gök F, Kabu Hergül F. cerrahi kliniklerinde yatan hastaların anksiyete ve depresyon düzeylerinin belirlenmesi. Sağlık Bilim İleri Araştırmalar Derg 2020;3(3):195-206. [CrossRef] google scholar
  • 6. Çırpan Kantarcıoğlu A, Demirkaya M, Sevinir BB. An Investigation of illness perception and emotional status in newly cancer-diagnosed adolescents. Turkish J Child Adolesc Ment Heal 2019;26(2):81-8. [CrossRef] google scholar
  • 7. Karayağmurlu A, Coşkun M, Pekpak E, Akbayram TH, Karayağmurlu E, Öğütlü H, et al. The assessment of quality of life, depression and anxiety in siblings of children with cancer: A case-control study. Turkish J Oncol 2021;36(1):521-9. [CrossRef] google scholar
  • 8. Karabulutlu EY, Bilici M, Çayir K, Tekin SB, Kantarci R. Coping, anxiety and depression in Turkish patients with cancer. Eur J Gen Med 2010;7(3):296-302. [CrossRef] google scholar
  • 9. Vardar-Yagli N, Sener G, Saglam M, Calik-Kutukcu E, Arikan H, Inal-Ince D, et al. Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors. Asian Pacific J Cancer Prev 2015;16(2):585-9. [CrossRef] google scholar
  • 10. Demirkol H. Kanser hastalarında James destekleyici bakım gereksinimlerini belirleme ölçeğinin geçerlik ve güvenirlik çalışması [Internet]. Ege Üniversitesi, Sağlık Bilimleri Enstitüsü; 2016. Available from: https://toad.halileksi.net/sites/default/ files/pdf/kanser-hastalarinda-james-destekleyici-bakim-gereksinimlerini-belirleme-olcegi-toad.pdf google scholar
  • 11. NCCN. Distress during cancer care. 2020; Available from: https://www.nccn.org/patients/guidelines/content/PDF/ distress-patient.pdf google scholar
  • 12. Miller MF, Mullins CD, Onukwugha E, Golant M, Buzaglo JS. Discriminatory power of a 25-item distress screening tool: a cross-sectional survey of 251 cancer survivors. Qual Life Res 2014;23(10):2855-63. [CrossRef] google scholar
  • 13. Gregorio SW-D, Porensky EK, Minotti M, Brown S, Snapp J, Taylor RM, et al. The James supportive care screening: integrating science and practice to meet the NCCN guidelines for distress management at a Comprehensive Cancer Center. Psychooncology 2013;22(9):1-18. [CrossRef] google scholar
  • 14. Güleç G, Büyükkınacı A. Kanser hastalarında psikiyatrik semptomlar. Psikiyatr Güncel Yaklaşımlar 2011;3(2):343-67. google scholar
  • 15. Jensen-Johansen MB, Christensen S, Valdimarsdottir H, Zakowski S, Jensen AB, Bovbjerg DH, et al. Effects of an expressive writing intervention on cancer-related distress in Danish breast cancer survivors - Results from a nationwide randomized clinical trial. Psychooncology 2013;22(7):1492-500. [CrossRef] google scholar
  • 16. Messina A, Fogliani AM, Paradiso S. Alexithymia in oncologic disease: Association with cancer invasion and hemoglobin levels. Ann Clin Psychiatry 2011;23(2):125-30. google scholar
  • 17. Güleç H, Köse S, Güleç MY, Çitak S, Evren C, Borckardt J, et al. Reliability and factorial validity of the Turkish version of the 20-item Toronto alexithymia scale (TAS-20). Klin Psikofarmakol Bul 2009;19(3):215-21. google scholar
  • 18. Şaşıoglu M, Gülol Ç, Tosun A. The Concept of alexithymia. Psikiyatr Güncel Yaklaşımlar -Curr Approaches Psychiatry 2013;5(4):507. [CrossRef] google scholar
  • 19. Freyberg H. Supportive psychotherapeutic tecniques in primary and secondary alexithymia 1977;28:337-42. [CrossRef] google scholar
  • 20. Hintistan S. Aleksitimi. Gümüşhane Üniversitesi Sağlık Bilim Derg 2012;1(4):333-46. google scholar
  • 21. Marrazzo G, Sideli L, Rizzo R, Marinaro AM, Mule A, Marrazzo A, et al. Quality of life, alexithymia, and defence mechanisms in patients affected by breast cancer across different stages of illness. J Psychopathol 2016;22(2):141-8. google scholar
  • 22. De Vries AMM, Forni V, Voellinger R, Stiefel F. Alexithymia in cancer patients: Review of the literature. Psychother Psychosom 2012;81(2):79-86. [CrossRef] google scholar
  • 23. Taylor GJ, Bagby RM, Parker JDA. The 20-Item Toronto alexithymia scale: IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res 2003;55(3):277-83. [CrossRef] google scholar
  • 24. Güleç H, Yenel A. 20 maddelik Toronto aleksitimi ölçeği Türkçe uyarlamasının kesme noktalarına göre psikometrik özellikleri. Klin Psikiyatr [Internet]. 2010;13:108-12. Available from: https://www.journalagent.com/kpd/pdfs/ KPD_13_3_108_112.pdf google scholar
  • 25. Karakas SA. Investigating alexithymia and social support in patients with hypertension and asthma. J Psychiatr Nurs 2016;7(2):68-74. [CrossRef] google scholar
  • 26. Orejuela-Dâvila AI, Cann A, Tedeschi RG. Alexithymia predicts posttraumatic growth and distress after trauma. J Loss Trauma 2017;22(3):171-82. [CrossRef] google scholar
  • 27. Conti C, Di Francesco G, Severo M, Lanzara R, Richards K, Guagnano MT, et al. Alexithymia and metabolic syndrome: the mediating role of binge eating. Eat Weight Disord 2020;(0123456789). [CrossRef] google scholar
  • 28. Di Tella M, Ghiggia A, Tesio V, Romeo A, Colonna F, Fusaro E, et al. Pain experience in Fibromyalgia Syndrome: The role of alexithymia and psychological distress. J Affect Disord [Internet]. 2017;208(October 2016):87-93. [CrossRef] google scholar
  • 29. Marchi L, Marzetti F, Orrîı G, Lemmetti S, Miccoli M, Ciacchini R, et al. Alexithymia and psychological distress in patients with fibromyalgia and rheumatic disease. Front Psychol 2019;10:1735. [CrossRef] google scholar
  • 30. McGillivray L, Becerra R, Harms C. Prevalence and demographic correlates of alexithymia: A comparison between Australian psychiatric and community samples. J Clin Psychol. 2017;73(1):76-87. [CrossRef] google scholar
  • 31. Preece DA, Becerra R, Boyes ME, Northcott C, McGillivray L, Hasking PA. Do self-report measures of alexithymia measure alexithymia or general psychological distress? A factor analytic examination across five samples. Pers Individ Dif 2020;155:1-8. [CrossRef] google scholar
  • 32. Vuillier L, Carter Z, Teixeira AR, Moseley RL. Alexithymia may explain the relationship between autistic traits and eating disorder psychopathology. Mol Autism 2020;11(1):63 [CrossRef] google scholar
  • 33. Taylor GJ, Bagby RM, Taylor GJ, Bagby RM. The Alexithymia personality dimension. The Oxford Handbook of Personality Disorders 2012. P. 647-73. [CrossRef] google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Ayhan, D., Mercan, N., Doğan, R., & Yüksel, Ç. (2021). INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER. Journal of Istanbul Faculty of Medicine, 84(2), 237-244. https://doi.org/10.26650/IUITFD.2020.0089


AMA

Ayhan D, Mercan N, Doğan R, Yüksel Ç. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER. Journal of Istanbul Faculty of Medicine. 2021;84(2):237-244. https://doi.org/10.26650/IUITFD.2020.0089


ABNT

Ayhan, D.; Mercan, N.; Doğan, R.; Yüksel, Ç. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 2, p. 237-244, 2021.


Chicago: Author-Date Style

Ayhan, Didem, and Neşe Mercan and Reyhan Doğan and Çiğdem Yüksel. 2021. “INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER.” Journal of Istanbul Faculty of Medicine 84, no. 2: 237-244. https://doi.org/10.26650/IUITFD.2020.0089


Chicago: Humanities Style

Ayhan, Didem, and Neşe Mercan and Reyhan Doğan and Çiğdem Yüksel. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER.” Journal of Istanbul Faculty of Medicine 84, no. 2 (May. 2024): 237-244. https://doi.org/10.26650/IUITFD.2020.0089


Harvard: Australian Style

Ayhan, D & Mercan, N & Doğan, R & Yüksel, Ç 2021, 'INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER', Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, pp. 237-244, viewed 17 May. 2024, https://doi.org/10.26650/IUITFD.2020.0089


Harvard: Author-Date Style

Ayhan, D. and Mercan, N. and Doğan, R. and Yüksel, Ç. (2021) ‘INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER’, Journal of Istanbul Faculty of Medicine, 84(2), pp. 237-244. https://doi.org/10.26650/IUITFD.2020.0089 (17 May. 2024).


MLA

Ayhan, Didem, and Neşe Mercan and Reyhan Doğan and Çiğdem Yüksel. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, 2021, pp. 237-244. [Database Container], https://doi.org/10.26650/IUITFD.2020.0089


Vancouver

Ayhan D, Mercan N, Doğan R, Yüksel Ç. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER. Journal of Istanbul Faculty of Medicine [Internet]. 17 May. 2024 [cited 17 May. 2024];84(2):237-244. Available from: https://doi.org/10.26650/IUITFD.2020.0089 doi: 10.26650/IUITFD.2020.0089


ISNAD

Ayhan, Didem - Mercan, Neşe - Doğan, Reyhan - Yüksel, Çiğdem. INVESTIGETING OF DISTRESS AND ALEXITHYMIA IN PATIENTS WITH HEMATOLOGICAL CANCER”. Journal of Istanbul Faculty of Medicine 84/2 (May. 2024): 237-244. https://doi.org/10.26650/IUITFD.2020.0089



TIMELINE


Submitted14.07.2020
Accepted04.01.2021
Published Online16.03.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.